ForagR Medicines
Biotechnology Research • • 1-10 Employees
Company overview
| Headquarters | XX |
| Website | |
| NAICS | 541714 |
| Founded | 2024 |
| Employees | 1-10 |
| Socials |
Key Contact at ForagR Medicines
Kevin Weeks
Founder
About ForagR Medicines
Built from the ground up, the ForagR Medicines RNA-centric, in-cell framework harnesses chemical genomics to stop diseases at their source The ForagR platform solves the challenges of selectivity, progressability, and function that have bedeviled small-molecule RNA-targeted medicines. Screening, hit-to-lead, and lead optimization are performed in cells to derisk targets, identify assets, and achieve functional modulation efficiently.
ForagR Medicines revenue & valuation
| Annual revenue | $342,220 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $1,100,000 |
| Total funding | No funding |
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Employees by Department
ForagR Medicines has 1 employees across 1 departments.
Departments
Number of employees
Funding Data
ForagR Medicines has never raised funding before.
United Kingdom
AustraliaFrequently asked questions
4.8
40,000 users
